VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_17-vv-00358
Package ID: USCOURTS-cofc-1_17-vv-00358
Petitioner: Anita Jones
Filed: 2018-07-18
Decided: 2018-07-19
Vaccine: Tdap
Vaccination date: 2015-02-09
Condition: Guillain-Barré syndrome (GBS)
Outcome: compensated
Award amount USD: 165192

AI-assisted case summary:
On July 18, 2018, Anita Jones filed a petition alleging that she suffered from Guillain-Barré syndrome (GBS) caused by a Tetanus-diphtheria-acellular pertussis (Tdap) vaccine administered on February 9, 2015. She further alleged that she experienced residual effects from the injury for more than six months. The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Ms. Jones's GBS. The parties reached a stipulation to resolve the case, agreeing to settlement terms. Special Master Laura D. Millman adopted the stipulation and awarded compensation. The award included a lump sum of $165,000.00 for all damages, payable to Anita Jones. Additionally, $192.38 was awarded to reimburse the State of Ohio Medicaid lien for services rendered on behalf of Ms. Jones. The decision was issued on July 19, 2018. Petitioner counsel was Simina Vourlis, and respondent counsel was Adriana R. Teitel. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert testimony.

Theory of causation field:
Petitioner Anita Jones alleged that a Tdap vaccine received on February 9, 2015, caused her Guillain-Barré syndrome (GBS) and that she experienced residual effects for more than six months. Respondent denied causation. The parties reached a stipulation to resolve the case, and the Special Master adopted the stipulation. The award included a lump sum of $165,000.00 for all damages and $192.38 for reimbursement of the State of Ohio Medicaid lien. The decision was issued by Special Master Laura D. Millman on July 19, 2018. The public decision does not specify the theory of causation, mechanism, or any expert testimony.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_17-vv-00358-0
Date issued/filed: 2018-08-13
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 07/19/2018) regarding 30 DECISION Stipulation/Proffer, Signed by Special Master Laura D Millman. (tlf) Service on parties made. Modified on 8/13/2018 (jt1).
--------------------------------------------------------------------------------
Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 17-358V
Filed: July 19, 2018
Not for Publication
*************************************
ANITA JONES, *
*
Petitioner, *
*
v. *
*
Damages decision based on
*
stipulation; Tetanus-diphtheria-
SECRETARY OF HEALTH *
acellular pertussis (“Tdap”)
AND HUMAN SERVICES, *
vaccine; Guillain-Barré syndrome
*
(“GBS”)
Respondent. *
*
*************************************
Simina Vourlis, Columbus, OH, for petitioner.
Adriana R. Teitel, Washington, DC, for respondent.
MILLMAN, Special Master
DECISION AWARDING DAMAGES1
On July 18, 2018, the parties filed the attached stipulation in which they agreed to settle
this case and described the settlement terms. Petitioner alleges that she suffered from Guillain-
Barré syndrome (“GBS”) that was caused by her receipt of Tetanus-diphtheria-acellular pertussis
(“Tdap”) vaccine on February 9, 2015. She further alleges that she experienced the residual effects
of this injury for more than six months. Respondent denies that the Tdap vaccine caused petitioner
to suffer GBS or any other injury. Nonetheless, the parties agreed to resolve this matter informally.
The undersigned finds the terms of the stipulation to be reasonable. The court hereby
1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this
case, the special master intends to post this unpublished decision on the United States Court of Federal
Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899,
2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made
available to the public unless they contain trade secrets or commercial or financial information that is
privileged and confidential, or medical or similar information whose disclosure would constitute a clearly
unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and
move to delete such information prior to the document’s disclosure. If the special master, upon review,
agrees that the identified material fits within the banned categories listed above, the special master shall
delete such material from public access.

Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 2 of 7
adopts the parties’ said stipulation, attached hereto, and awards compensation in the amount and
on the terms set for therein. Pursuant to the stipulation, the court awards:
a. a lump sum of $165,000.00, in the form of a check payable to petitioner representing
compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a);
b. a lump sum of $192.38, representing reimbursement of the State of Ohio Medicaid lien
for services rendered on behalf of petitioner in the form of a check payable jointly to
petitioner and
Ohio Tort Recovery Unit
350 Worthington Rd., Suite G
Westerville, OH 43082
Case Number: 1086377
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the
court is directed to enter judgment herewith.2
IT IS SO ORDERED.
Dated: July 19, 2018 s/ Laura D. Millman
Laura D. Millman
Special Master
2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or
jointly, filing a notice renouncing the right to seek review.
2

Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 3 of 7

Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 4 of 7

Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 5 of 7

Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 6 of 7

Case 1:17-vv-00358-UNJ Document 34 Filed 08/13/18 Page 7 of 7